ImmunityBio, Inc. announced that its pivotal randomized BCG-naive non-muscle invasive bladder cancer (NMIBC) trial has demonstrated sufficient statistical power to detect clinically meaningful differences between the Anktiva® plus BCG treatment regimen and BCG alone.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The company also confirmed that the supplemental Biologics License Application (BLA) for the therapy is progressing as planned, with a target completion in 2026.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Australian Dollar : Key support at 0.6935 in focus against US Dollar – UOB
FXStreet•2026/10/13 14:21
BUZZ - Krispy Kreme shares rise on New York expansion deal
路透社•2026/10/13 14:06
Crypto prices
More
Bitcoin
BTC
$83,617.11
+1.42%
Ethereum
ETH
$2,522.65
+0.27%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$744.68
-0.06%
XRP
XRP
$1.38
-0.01%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$107.86
-0.78%
TRON
TRX
$0.3273
-1.07%
Hyperliquid
HYPE
$81.72
-2.97%
Zcash
ZEC
$1,202.84
-5.23%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now